Consumer HealthCare

Ipsen’s long-standing expertise spans the value chain, from active principle to finished product to the patient, with special expertise in gastrointestinal (GI) disorders, neurodegenerative pathologies and rheumatology, as well as a constantly expanding portfolio. We are also establishing a growing sustainable and autonomous Consumer Healthcare business.

Consumer HealthCare

We dare because we care

At Ipsen Consumer HealthCare, we continually reinvent ourselves to daily relieve global consumers’ pains, and improve their well-being, anytime, anywhere. We’re committed to developing new treatments and new approaches to improve the everyday life of as many people as possible and be a key partner for health professionals.

Strategy and vision

Ipsen is establishing a growing, autonomous and sustainable Consumer HealthCare business. Building on a rich heritage in primary care and gastrointestinal treatments, we aim at developing a portfolio of well recognized brands for the benefit of patients and consumers across the world.

Our brands

10 key brands related to 4 therapeutic areas: gastroenterology, cognitive disorders, pain, cough and cold.

Consumer HealthCare

Strategy & Vision

Who we are

For more than 45 years, we have developed a special expertise in gastrointestinal (GI) disorders. A long-standing expertise and a willingness to evolve enable us to constantly expand our portfolio. 

  • More than 60% of revenues are realized in gastroenterology
  • Revenues are now generated by both physician prescriptions, pharmacists’ recommendations and the direct requests of patients
  • A presence in 70 countries, with 3 key emerging markets (China, Russia and Algeria), making us a major player in gastrointestinal (GI) disorders.

Our philosophy

We believe that everyday health problems have to be treated with the same commitment and passion for patients as more profound health issues. A careful approach, where the patients’ expectations are always our starting point in developing dedicated products that are adapted to his or her way of life; not the other way round.

Our Mission is to provide healthcare solutions Consumer Oriented, Innovative & Available Worldwide

Our ambition

To establish a growing, autonomous and sustainable healthcare business.
Over the years we have developed a portfolio of well-known brands that we continue to consolidate. These strong foundations have led us to strengthen our position in key European markets (France, Italy), and capture market growth in emerging markets such as Russia and China.
In addition to leveraging our three key brands (SMECTA®, FORLAX® & TANAKAN®), we are extending our capabilities to include medical devices and food supplements.

Strategy & Vision

The whole team is fully committed to establish a growing, autonomous and sustainable Consumer Healthcare business”


Benoît Hennion, Executive Vice President and President, Consumer HealthCare

Our history

Ipsen’s history shows how entrepreneurship, ambition and tenacity have transformed the small-town French pharmacy created in 1929, into a global leader in specialty care. With this same mindset, we are transforming our heritage in primary care into a successful Consumer HealthCare division with a global outlook.

Ipsen’s long-standing expertise in consumer Healthcare spans the value chain, from active ingredient, to finished product, to the patient, with special expertise, in gastrointestinal (GI) disorders.

Over the decades, we have developed an expertise in clay-based products as well as Gingko Biloba natural extracts. This expertise has led to the launch of brands such as SMECTA® for diarrhea, FORLAX® for constipation, FORTRANS® and EZICLEN®/IZINOVA® colon-cleansing solutions, TANAKAN® for cognitive disorders.

As an illustration of our recent transformation, 4 recent actions are highlighted:

2015

We have been revitalizing this activity by enriching our capabilities, reinforcing our portfolio and expanding our geographical footprint.

New formulations and new partnerships have been developed to better serve the needs of patients around the world.

2016

We signed an agreement with the Swedish firm Probi for the commercialization of the probiotic strain Lactobacillus plantarum 299v (LP299V®).

2017

We acquired (from Sanofi) five consumer healthcare products in certain European territories. This transaction further accelerated the development of our Consumer HealthCare business and our conversion into an OTx (combined prescription and over-the-counter) business model.

2018

We acquired 100% of the Italian company Akkadeas Pharma, whose diversified portfolio includes probiotics, medical devices and food supplements. In addition to providing a springboard for Ipsen’s future development in Italy, Akkadeas has become our Italian distributor for SMECTA® (distributed under the brand name DISOMECTAL® in Italy).

Our history

Our brands

 

Our People

Our 1600 colleagues worldwide are the ambassadors who truly make the difference for building a growing, autonomous and sustainable Consumer HealthCare business.

Joining Ipsen Consumer HealthCare you will:

  • Work for a global company with human size and a start-up mindset. Agility, entrepreneurship, test and learn spirit and trust are central in our philosophy of doing business.
  • Contribute to improve the health and well-being of thousands of patients’ and families, with innovative spirit and no compromise on quality in everything we do.
  • Benefit from a collaborative and opened-minded culture which offers a wealth of opportunities for talented people.

Our people

illus_research

Careers

Ipsen offers exciting opportunities that will challenge your abilities, expand your skills and reward your contribution in a positive atmosphere of personal and professional development.

Search for a Job
© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2019